Biogen reported $586.8M in Pre-Tax Profit for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Bluebird Bio BLUE:US $ -132.24M 84.69M
Novartis NOVN:VX SF 3682M 862M
Sangamo Biosciences SGMO:US $ -43.92M 6.36M
Teva Pharmaceutical TEVA:IT -175000000 557M